Baltic Heart Study- effects of telemedicine and distancelearning applications in the prevention of chronic heart failure
- Conditions
- Chronic heart failureCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12611000834954
- Lead Sponsor
- European Commission
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 792
1. Written informed consent obtained.
2. Male and female patients over 18 years of age.
3. Chronic heart failure diagnosed at least before study involvement. Treated
with relevant long-term oral treatment.
4. Relevant NYHA II-III symptoms at screening and at baseline.
1. NYHA I or IV
2. Therapeutic education impossible
3. Severe renal insufficiency (serum creatinine >450 mmol/l [5.0 mg/dl]) or on dialysis
4. Severe anaemia (blood haemoglobin <10 g/dl) at screening
5. Other serious diseases limiting life expectancy considerably (e.g. end-stage cancer)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method